<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33575923</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Mayan alleles of the HLA-DRB1 major histocompatibility complex might contribute to the genetic susceptibility to systemic lupus erythematosus in Mexican patients from Tapachula, Chiapas.</ArticleTitle><Pagination><StartPage>3095</StartPage><EndPage>3103</EndPage><MedlinePgn>3095-3103</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-021-05636-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is the prototypic autoimmune disease that disrupts numerous immunity mechanisms with the potential to exert damage to any organ or tissue. Its etiology remains uncertain; however, genetic and environmental factors that differ between populations strongly influence its development. Among the physiopathogenic factors, the genetic ones predominate, notably the major histocompatibility complex (MHC) loci. A high degree of ethnical admixture makes Mexican Mestizos a thoroughly genetically heterogeneous population. Therefore, this study aimed to identify the MHC polymorphisms associated with SLE development in Mexican Mestizos from Southern Mexico and compare them with patients from Mexico City.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A transversal study in SLE patients from Tapachula, Chiapas, was conducted. DNA typing of human leukocyte antigens (HLA) classes I and II was performed using single specific primers (SSP). Admixture analysis was performed using the population genetics LEADMIX software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The frequencies of HLA-DRB1*16 and HLA-DQB1*05 were found to have a tendency towards increase in SLE patients, compared to ethnically matched healthy controls. The allele HLA-DRB1*03 seemed to be less associated with SLE in this group of Mexican Mestizos, opposed to other more Caucasian populations. Admixture analysis showed a higher Mayan genetic component in these patients from Chiapas.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The genetic susceptibility for SLE differed in two populations of Mexican Mestizos with dissimilar ethnic ancestries. Autochthonous Amerindian alleles, and not the more widely known Caucasian alleles, might be associated with the susceptibility to SLE in Mexican Mestizos from Tapachula, Chiapas. Key Points &#x2022; Autochthonous Amerindian alleles, such as HLA-DRB1*16, had a tendency to be increased in SLE patients, compared to healthy controls. &#x2022; SLE susceptibility alleles vary considerably among regions in Mexico, according to the distribution of the indigenous groups. &#x2022; Ethnic admixture is a key determinant in the genetic susceptibility of SLE.</AbstractText><CopyrightInformation>&#xa9; 2021. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia-Silva</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4537-3180</Identifier><AffiliationInfo><Affiliation>Department of Transplantation, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Do&#xf1;o</LastName><ForeName>Susana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6949-7081</Identifier><AffiliationInfo><Affiliation>Department of Transplantation, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rom&#xe1;n-Amparo</LastName><ForeName>Jeniffer Patricia</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-3653-1412</Identifier><AffiliationInfo><Affiliation>Research Division, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo-Vizuet</LastName><ForeName>Ma Guadalupe</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-8512-2530</Identifier><AffiliationInfo><Affiliation>Escuela Nacional de Ciencias Biol&#xf3;gicas, Instituto Polit&#xe9;cnico Nacional, Ciudad de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena-Vela</LastName><ForeName>Blanca Aurora</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0001-8225-0422</Identifier><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizo-Pinto</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2120-0875</Identifier><AffiliationInfo><Affiliation>Research Division, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirado</LastName><ForeName>Jos&#xe9; Manuel P&#xe9;rez</ForeName><Initials>JMP</Initials><Identifier Source="ORCID">0000-0003-1945-7919</Identifier><AffiliationInfo><Affiliation>Hospital Regional de Alta Especialidad Ciudad Salud, Centro Regional de Alta Especialidad de Chiapas, Carretera Puerto Madero s / n Km 15-200, C.P. 30830, Puerto Madero, Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cetina-D&#xed;az</LastName><ForeName>Jos&#xe9; Hiram</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-0908-5218</Identifier><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulos-Rodr&#xed;guez</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granados</LastName><ForeName>Julio</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8553-1027</Identifier><AffiliationInfo><Affiliation>Department of Transplantation, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sep&#xfa;lveda-Delgado</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1393-653X</Identifier><AffiliationInfo><Affiliation>Research Division, Hospital Regional de Alta Especialidad "Ciudad Salud", Tapachula, Chiapas, Mexico. jesussd52@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Regional de Alta Especialidad Ciudad Salud, Centro Regional de Alta Especialidad de Chiapas, Carretera Puerto Madero s / n Km 15-200, C.P. 30830, Puerto Madero, Tapachula, Chiapas, Mexico. jesussd52@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coordinaci&#xf3;n Cl&#xed;nica de Medicina, Hospital General de Zona No.1 Nueva Frontera IMSS, Tapachula, Chiapas, Mexico. jesussd52@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina Humana C-IV, Universidad Aut&#xf3;noma de Chiapas, Tapachula, Chiapas, Mexico. jesussd52@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019 12 M7A 3 3 01 00 024 E022 25901</GrantID><Agency>Centro Regional de Alta Especialidad de Chiapas</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="Y">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008285" MajorTopicYN="N">Major Histocompatibility Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA</Keyword><Keyword MajorTopicYN="N">Immunogenetics</Keyword><Keyword MajorTopicYN="N">Mexican Mestizos</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33575923</ArticleId><ArticleId IdType="doi">10.1007/s10067-021-05636-4</ArticleId><ArticleId IdType="pii">10.1007/s10067-021-05636-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB (2018) The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene 668:59&#x2013;72. https://doi.org/10.1016/j.gene.2018.05.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.05.041</ArticleId><ArticleId IdType="pubmed">29775752</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39(4):257&#x2013;268. https://doi.org/10.1016/j.semarthrit.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.10.007</ArticleId><ArticleId IdType="pubmed">19136143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastiani GD, Galeazzi M (2009) Immunogenetic studies on systemic lupus erythematosus. Lupus 18(10):878&#x2013;883. https://doi.org/10.1177/0961203309106918</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309106918</ArticleId><ArticleId IdType="pubmed">19671786</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Ahearn JM (2009) The search for lupus biomarkers. Best Pract Res Clin Rheumatol 23(4):507&#x2013;523. https://doi.org/10.1016/j.berh.2009.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2009.01.008</ArticleId><ArticleId IdType="pubmed">19591781</ArticleId><ArticleId IdType="pmc">2727983</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro-Dominguez D, Lopez-Dominguez R, Garcia Moreno A, Villatoro-Garcia JA, Martorell-Marugan J, Goldman D, Petri M, Wojdyla D, Pons-Estel BA, Isenberg D, Morales-Montes de Oca G, Trejo-Zambrano MI, Garcia Gonzalez B, Rosetti F, Gomez-Martin D, Romero-Diaz J, Carmona-Saez P, Alarcon-Riquelme ME (2019) Differential treatments based on drug-induced gene expression signatures and longitudinal systemic lupus erythematosus stratification. Sci Rep 9(1):15502. https://doi.org/10.1038/s41598-019-51616-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-51616-9</ArticleId><ArticleId IdType="pubmed">31664045</ArticleId><ArticleId IdType="pmc">6820741</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes B, Vyse TJ (2008) The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 47(11):1603&#x2013;1611. https://doi.org/10.1093/rheumatology/ken247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Brown EE, Kimberly RP, Langefeld CD (2010) Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 30(2):164&#x2013;176. https://doi.org/10.1016/j.semnephrol.2010.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2010.01.007</ArticleId><ArticleId IdType="pubmed">20347645</ArticleId><ArticleId IdType="pmc">2847514</ArticleId></ArticleIdList></Reference><Reference><Citation>Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, Straaton KV, Alarcon GS (1998) Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 41(7):1161&#x2013;1172. https://doi.org/10.1002/1529-0131(199807)41:7&lt;1161::AID-ART4&gt;3.0.CO;2-K</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199807)41:7&lt;1161::AID-ART4&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">9663471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccarelli F, Perricone C, Borgiani P, Ciccacci C, Rufini S, Cipriano E, Alessandri C, Spinelli FR, Sili Scavalli A, Novelli G, Valesini G, Conti F (2015) Genetic factors in systemic lupus erythematosus: contribution to disease phenotype. J Immunol Res 2015:745647&#x2013;745611. https://doi.org/10.1155/2015/745647</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/745647</ArticleId><ArticleId IdType="pubmed">26798662</ArticleId><ArticleId IdType="pmc">4699011</ArticleId></ArticleIdList></Reference><Reference><Citation>Granados J, Z&#xfa;&#xf1;iga J, Acu&#xf1;a-Alonzo V, Rosetti F, Vargas-Alarc&#xf3;n G (2006) Influencia de alelos y haplotipos del complejo principal de histocompatibilidad en la susceptibilidad a lupus eritematoso generalizado en la poblaci&#xf3;n mexicana. Gac Med Mex 142:195&#x2013;199</Citation><ArticleIdList><ArticleId IdType="pubmed">16875346</ArticleId></ArticleIdList></Reference><Reference><Citation>Reveille JD, Moulds JM, Arnett FC (1995) Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus. Tissue Antigens 45(2):91&#x2013;97. https://doi.org/10.1111/j.1399-0039.1995.tb02423.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.1995.tb02423.x</ArticleId><ArticleId IdType="pubmed">7792766</ArticleId></ArticleIdList></Reference><Reference><Citation>Penaranda-Parada E, Quintana G, Yunis JJ, Mantilla R, Rojas W, Panqueva U, Caminos JE, Garces MF, Sanchez E, Rondon-Herrera F, de Jesus Iglesias-Gamarra A (2015) Clinical, serologic, and immunogenetic characterization (HLA-DRB1) of late-onset lupus erythematosus in a Colombian population. Lupus 24(12):1293&#x2013;1299. https://doi.org/10.1177/0961203315588576</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315588576</ArticleId><ArticleId IdType="pubmed">26022697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yamanaka K, Tokano Y, Murashima A, Kabasawa K, Hirose S (1994) HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 23(4):191&#x2013;196. https://doi.org/10.3109/03009749409103059</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009749409103059</ArticleId><ArticleId IdType="pubmed">8091144</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E, Williams A, Beck S, Kyogoku C, Moser K, Gaffney P, Gregersen PK, Criswell LA, Harley JB, Behrens TW (2007) Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15(8):823&#x2013;830. https://doi.org/10.1038/sj.ejhg.5201827</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejhg.5201827</ArticleId><ArticleId IdType="pubmed">17406641</ArticleId></ArticleIdList></Reference><Reference><Citation>Barquera R, Zuniga J, Hernandez-Diaz R, Acuna-Alonzo V, Montoya-Gama K, Moscoso J, Torres-Garcia D, Garcia-Salas C, Silva B, Cruz-Robles D, Arnaiz-Villena A, Vargas-Alarcon G, Granados J (2008) HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol 45(4):1171&#x2013;1178. https://doi.org/10.1016/j.molimm.2007.07.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2007.07.042</ArticleId><ArticleId IdType="pubmed">17904223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sep&#xfa;lveda-Delgado JD-LR, Oca&#xf1;a-Sibilla MJ, Ramir&#xed;ez-Valdespino JCC-DJ, Bulos Rodriguez P, Hern&#xe1;ndez-Do&#xf1;o S, Ruiz Gomez D, Garc&#xed;a R, Ju&#xe1;rez-Nicol&#xe1;s FT-GM, Vera Lastra OL, Jara LJ, Canseco-&#xc1;vila LM, Dominguez-Arrevillaga ST-MK, Granados J (2018) Role of HLA DRB1*15 and HLA DRB1*16 alleles in the genetic susceptibility to develop systemic lupus erythematosus (SLE) after Chikungunya and Zika viruses infection in M&#xe9;xico. APJBG 2(4):4</Citation></Reference><Reference><Citation>Lundstrom E, Gustafsson JT, Jonsen A, Leonard D, Zickert A, Elvin K, Sturfelt G, Nordmark G, Bengtsson AA, Sundin U, Kallberg H, Sandling JK, Syvanen AC, Klareskog L, Gunnarsson I, Ronnblom L, Padyukov L, Svenungsson E (2013) HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis 72(6):1018&#x2013;1025. https://doi.org/10.1136/annrheumdis-2012-201760</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-201760</ArticleId><ArticleId IdType="pubmed">22893315</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Estrada A, Gignoux CR, Fernandez-Lopez JC, Zakharia F, Sikora M, Contreras AV, Acuna-Alonzo V, Sandoval K, Eng C, Romero-Hidalgo S, Ortiz-Tello P, Robles V, Kenny EE, Nuno-Arana I, Barquera-Lozano R, Macin-Perez G, Granados-Arriola J, Huntsman S, Galanter JM, Via M, Ford JG, Chapela R, Rodriguez-Cintron W, Rodriguez-Santana JR, Romieu I, Sienra-Monge JJ, del Rio Navarro B, London SJ, Ruiz-Linares A, Garcia-Herrera R, Estrada K, Hidalgo-Miranda A, Jimenez-Sanchez G, Carnevale A, Soberon X, Canizales-Quinteros S, Rangel-Villalobos H, Silva-Zolezzi I, Burchard EG, Bustamante CD (2014) Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 344(6189):1280&#x2013;1285. https://doi.org/10.1126/science.1251688</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1251688</ArticleId><ArticleId IdType="pubmed">24926019</ArticleId><ArticleId IdType="pmc">4156478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F, Alvarellos A, Alarcon-Segovia D, Grupo Latinoamericano de Estudio del L (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among &#x201c;Hispanics&#x201d;. Medicine (Baltimore) 83(1):1&#x2013;17. https://doi.org/10.1097/01.md.0000104742.42401.e2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000104742.42401.e2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte-Gil MF, Pons-Estel GJ, Molineros J, Wojdyla D, McGwin G Jr, Nath SK, Pons-Estel BA, Alarcon-Riquelme M, Alarcon GS (2016) Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary. Rheumatology (Oxford) 55(3):436&#x2013;440. https://doi.org/10.1093/rheumatology/kev280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kev280</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vasquez EM, Abadi I, Wojdyla D, Alarcon-Riquelme ME, Alarcon GS, Pons-Estel BA, Gladel (2015) Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus 24(6):536&#x2013;545. https://doi.org/10.1177/0961203314567753</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314567753</ArticleId><ArticleId IdType="pubmed">25697768</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Alarcon G, Granados J, Rodriguez-Perez JM, Parga C, Perez-Hernandez N, Rey D, Zuniga J, Arnaiz-Villena A (2010) Distribution of HLA class II alleles and haplotypes in Mexican Mestizo population: comparison with other populations. Immunol Investig 39(3):268&#x2013;283. https://doi.org/10.3109/08820131003681151</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08820131003681151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J (2003) Maximum-likelihood estimation of admixture proportions from genetic data. Genetics 164(2):747&#x2013;765</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/164.2.747</ArticleId></ArticleIdList></Reference><Reference><Citation>Granados J, Vargas-Alarcon G, Andrade F, Melin-Aldana H, Alcocer-Varela J, Alarcon-Segovia D (1996) The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans. Lupus 5(3):184&#x2013;189. https://doi.org/10.1177/096120339600500304</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339600500304</ArticleId><ArticleId IdType="pubmed">8803888</ArticleId></ArticleIdList></Reference><Reference><Citation>Granados J, Vargas-Alarc&#xf3;n G, Drenkard C, Andrade F, Mel&#xed;n-Aldana H, Alcocer-Varela J, Alarc&#xf3;n-Segovia D (1997) Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus 6(1):57&#x2013;62. https://doi.org/10.1177/096120339700600108</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339700600108</ArticleId><ArticleId IdType="pubmed">9116720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F (2004) HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum Immunol 65(12):1469&#x2013;1476. https://doi.org/10.1016/j.humimm.2004.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2004.09.008</ArticleId><ArticleId IdType="pubmed">15603875</ArticleId></ArticleIdList></Reference><Reference><Citation>Salgado-Galicia NA, Hern&#xe1;ndez-Do&#xf1;o S, Ruiz-G&#xf3;mez D, Jakez-Ocampo J, Z&#xfa;&#xf1;iga J, Vargas-Alarc&#xf3;n G, Acu&#xf1;a V, Hern&#xe1;ndez MT, M&#xe1;rquez-Garc&#xed;a JE, Garc&#xed;a-Lechuga M, Llorente L, Lima G, Pineda C, Yu N, Yunis E, Granados J (2020) The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients. Clin Rheumatol 39(7):2151&#x2013;2161. https://doi.org/10.1007/s10067-020-04928-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-04928-5</ArticleId><ArticleId IdType="pubmed">32008155</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Tello A, Rodriguez-Carreon AA, Jurado F, Yamamoto-Furusho JK, Castillo-Vazquez M, Chavez-Munoz C, Salgado N, Arellano-Campos O, Vargas-Alarcon G, Granados J (2007) Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients. Clin Exp Dermatol 32(4):435&#x2013;438. https://doi.org/10.1111/j.1365-2230.2007.02391.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2230.2007.02391.x</ArticleId><ArticleId IdType="pubmed">17376212</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Hidalgo S, Flores-Rivera J, Rivas-Alonso V, Barquera R, Villarreal-Molina MT, Antuna-Puente B, Macias-Kauffer LR, Villalobos-Comparan M, Ortiz-Maldonado J, Yu N, Lebedeva TV, Alosco SM, Garcia-Rodriguez JD, Gonzalez-Torres C, Rosas-Madrigal S, Ordonez G, Guerrero-Camacho JL, Trevino-Frenk I, Escamilla-Tilch M, Garcia-Lechuga M, Tovar-Mendez VH, Pacheco-Ubaldo H, Acuna-Alonzo V, Bortolini MC, Gallo C, Bedoya G, Rothhammer F, Gonzalez-Jose R, Ruiz-Linares A, Canizales-Quinteros S, Yunis E, Granados J, Corona T (2020) Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population. Sci Rep 10(1):13706. https://doi.org/10.1038/s41598-020-69224-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69224-3</ArticleId><ArticleId IdType="pubmed">32792643</ArticleId><ArticleId IdType="pmc">7426416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Alarcon G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J, Arnaiz-Villena A, Alarcon-Segovia D (2001) Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol 62(8):814&#x2013;820. https://doi.org/10.1016/s0198-8859(01)00267-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0198-8859(01)00267-1</ArticleId><ArticleId IdType="pubmed">11476905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s-Corona LF, Hern&#xe1;ndez-Do&#xf1;o S, Rodr&#xed;guez-Reyna TS, Garc&#xed;a-Silva R, Jakez J, Escamilla-Tilch M, Lima G, Llorente L, Pineda C, Yunis E, Granados J (2020) Aspartic acid70 in the HLA-DRB1 chain and shared epitope alleles partially explain the high prevalence of autoimmunity in Mexicans. J Transl Autoimmun 3:100057. https://doi.org/10.1016/j.jtauto.2020.100057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100057</ArticleId><ArticleId IdType="pubmed">32743537</ArticleId><ArticleId IdType="pmc">7388401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga J, Yu N, Barquera R, Alosco S, Ohashi M, Lebedeva T, Acuna-Alonzo V, Yunis M, Granados-Montiel J, Cruz-Lagunas A, Vargas-Alarcon G, Rodriguez-Reyna TS, Fernandez-Vina M, Granados J, Yunis EJ (2013) HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS One 8(9):e74442. https://doi.org/10.1371/journal.pone.0074442</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074442</ArticleId><ArticleId IdType="pubmed">24086347</ArticleId><ArticleId IdType="pmc">3781075</ArticleId></ArticleIdList></Reference><Reference><Citation>Barquera R, Zuniga J, Flores-Rivera J, Corona T, Penman BS, Hernandez-Zaragoza DI, Soler M, Jonapa-Gomez L, Mallempati KC, Yescas P, Ochoa-Morales A, Barsakis K, Aguilar-Vazquez JA, Garcia-Lechuga M, Mindrinos M, Yunis M, Jimenez-Alvarez L, Mena-Hernandez L, Ortega E, Cruz-Lagunas A, Tovar-Mendez VH, Granados J, Fernandez-Vina M, Yunis E (2020) Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans. Sci Rep 10(1):3248. https://doi.org/10.1038/s41598-020-58897-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58897-5</ArticleId><ArticleId IdType="pubmed">32094421</ArticleId><ArticleId IdType="pmc">7039995</ArticleId></ArticleIdList></Reference><Reference><Citation>Acuna-Soto R, Stahle DW, Therrell MD, Griffin RD, Cleaveland MK (2004) When half of the population died: the epidemic of hemorrhagic fevers of 1576 in Mexico. FEMS Microbiol Lett 240(1):1&#x2013;5. https://doi.org/10.1016/j.femsle.2004.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.femsle.2004.09.011</ArticleId><ArticleId IdType="pubmed">15500972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>